ArticleCell reports methods2026
Cross-species integration of single-cell data reveals conserved pathology-associated cell populations across animal models and human samples.
Article in Cell reports methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell RNA sequencing (scRNA-seq) enables high-resolution profiling of cellular heterogeneity, but integrating data across species remains challenging due to technical variation and complex gene homology. We present TACMAN (transformer-based alignment of cross-species metapath aggregation network), a computational framework for cross-species scRNA-seq integration that combines a metapath-based heterogeneous graph neural network with an encoder-only transformer. TACMAN aligns conserved cell types across species under normal physiological conditions while preserving biological signals. We demonstrate its utility by integrating clinical human and mammalian model scRNA-seq data, revealing conserved cell subtypes in tumor, inflammatory, and infectious diseases. Notably, using our in-house single-cell transcriptomic atlas of an evolutionarily distant Caenorhabditis elegans germline tumor model, TACMAN identifies tumor-related cell populations conserved in human testicular germ cell tumor samples, enabling cross-species comparison under pathological conditions. TACMAN thus offers a powerful tool for comparative single-cell analysis, advancing translational research using animal models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.